Gene drive debate must include voices from Africa, elsewhere
By Richard Nchabi Kamwi,
STAT
| 06. 15. 2016
As the spread of mosquito-borne diseases has captured headlines in recent months, so too has a novel approach to mosquito control that might one day stop them: gene drive. Although it is in early development, this promising genetic technique could help end the transmission of many deadly pathogens, including malaria.
Gene drives let modifications made to a single organism spread rapidly through the entire population by making sure that targeted genes are passed on to nearly all its offspring. In theory, it would be possible to use gene drives to create mosquitoes that produce sterile offspring, vastly reducing the number that can transmit malaria or other viruses.
...
While vitally important, these conversations have been missing something invaluable: the perspectives of representatives from malaria-affected countries, largely in South and Central America, Africa, and southern Asia.
Continue reading on STAT
Image via Wikimedia
Related Articles
By Danny Finley, Bill of Health | 01.08.2026
The United States Food and Drug Administration (FDA) has a unique funding structure among federal scientific and health agencies. The industries it regulates fund nearly half of its budget. The agency charges companies a user fee for each application
...
By George Janes, BioNews | 01.12.2026
A heart attack patient has become the first person to be treated in a clinical trial of an experimental gene therapy, which aims to strengthen blood vessels after coronary bypass surgery.
Coronary artery bypass surgery is performed to treat...
By Nick Paul Taylor, Fierce Biotech | 01.09.2026
Menlo Ventures has made a $16 million bet that the “baby KJ” custom CRISPR therapy success story is repeatable. The funding has enabled CRISPR co-inventor Jennifer Doudna, Ph.D., and baby KJ scientist Fyodor Urnov, Ph.D., to launch Aurora...
By David Cox, Wired | 01.05.2026
As he addressed an audience of virologists from China, Australia, and Singapore at October’s Pandemic Research Alliance Symposium, Wei Zhao introduced an eye-catching idea.
The gene-editing technology Crispr is best known for delivering groundbreaking new therapies for rare diseases, tweaking...